| Product Code: ETC7552433 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India rare neurological disease treatment market import shipments exhibited exceptional growth with a notable CAGR from 2020 to 2024. The growth rate surged notably between 2023 and 2024, indicating a rapid expansion trend in the market. The market showed strong momentum and significant overall growth during this period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Rare Neurological Disease Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Rare Neurological Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Rare Neurological Disease Treatment Market - Industry Life Cycle |
3.4 India Rare Neurological Disease Treatment Market - Porter's Five Forces |
3.5 India Rare Neurological Disease Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Rare Neurological Disease Treatment Market Revenues & Volume Share, By Administration, 2021 & 2031F |
4 India Rare Neurological Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about rare neurological diseases in India |
4.2.2 Growing investments in healthcare infrastructure and research and development |
4.2.3 Rise in government initiatives and funding for rare disease treatments |
4.3 Market Restraints |
4.3.1 High cost of treatment and limited access to advanced therapies |
4.3.2 Lack of skilled healthcare professionals in the field of rare neurological disease treatment |
5 India Rare Neurological Disease Treatment Market Trends |
6 India Rare Neurological Disease Treatment Market, By Types |
6.1 India Rare Neurological Disease Treatment Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Rare Neurological Disease Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 India Rare Neurological Disease Treatment Market Revenues & Volume, By Biologics, 2021- 2031F |
6.1.4 India Rare Neurological Disease Treatment Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.2 India Rare Neurological Disease Treatment Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 India Rare Neurological Disease Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.3 India Rare Neurological Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
7 India Rare Neurological Disease Treatment Market Import-Export Trade Statistics |
7.1 India Rare Neurological Disease Treatment Market Export to Major Countries |
7.2 India Rare Neurological Disease Treatment Market Imports from Major Countries |
8 India Rare Neurological Disease Treatment Market Key Performance Indicators |
8.1 Number of clinical trials for rare neurological disease treatments conducted in India |
8.2 Adoption rate of innovative treatment technologies for rare neurological diseases |
8.3 Number of specialized healthcare centers established for rare neurological disease treatment in India |
9 India Rare Neurological Disease Treatment Market - Opportunity Assessment |
9.1 India Rare Neurological Disease Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Rare Neurological Disease Treatment Market Opportunity Assessment, By Administration, 2021 & 2031F |
10 India Rare Neurological Disease Treatment Market - Competitive Landscape |
10.1 India Rare Neurological Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Rare Neurological Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here